Preliminary results from the phase IV study “insufficient” or “inconclusive” samples were presented at 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015) held in Nice (France).
In this study we tested the capacity of GynEC®-DX to exploit endometrial aspirates from patients that had an inconclusive result in Anatomical Pathology.
